omeprazole has been researched along with atropine in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (20.69) | 18.7374 |
| 1990's | 16 (27.59) | 18.2507 |
| 2000's | 20 (34.48) | 29.6817 |
| 2010's | 9 (15.52) | 24.3611 |
| 2020's | 1 (1.72) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Fung, L; Greenberg, GR; Pokol-Daniel, S | 1 |
| Fujii, N; Fukuda, H; Funakoshi, A; Funakoshi, S; Kitani, K; Miyasaka, K; Nakamura, J | 1 |
| Feldman, M; Lin, HJ; McArthur, KE; Prince, MD; Redfern, JS | 1 |
| Harding, M; Hayward, NJ; Hughes, J; Lloyd, SA; McKnight, AT; Woodruff, GN | 1 |
| Fields, JZ; Haydek, JM; Keshavarzian, A; Stinneford, JG; Zepeda, DO | 1 |
| Fryklund, J; Gedda, K; Sachs, G; Scott, D; Wallmark, B | 1 |
| Guth, PH; Leung, FW; Raybould, HE; Taché, Y; Thiefin, G | 1 |
| De Graef, J; Simoens, C; Woussen-Colle, MC | 1 |
| Batzri, S; Brugada, O; Harmon, JW; Rich, NM | 1 |
| Katsuyama, Y; Watanabe, K; Yano, S | 1 |
| Britanisky, R; White, JF | 1 |
| Ohno, T; Okabe, S | 1 |
| Hansson, HA; Helander, HF; Holmgren, A; Rozell, B | 1 |
| Hirose, N; Ishihara, T; Ohno, T; Okabe, S; Uramoto, H | 1 |
| Ishihara, T; Ohno, T; Okabe, S; Uramoto, H | 1 |
| Blum, AL; Fimmel, CJ | 1 |
| Berglindh, T; Elander, B; Fellenius, E; Olbe, L; Sachs, G; Sjöstrand, SE; Wallmark, B | 1 |
| Fryklund, J; Helander, HF; Larsson, H; Wallmark, B | 1 |
| Helander, HF; Sundell, GW | 1 |
| Ito, M; Kojima, R; Segami, T; Suzuki, Y; Tsukahara, T | 1 |
| Furusawa, A; Kaneko, H; Maeda, Y; Mitsuma, T; Morise, K; Nagai, H; Nakada, K; Uchida, K | 1 |
| Dalenbäck, J; Fändriks, L; Olbe, L; Sjövall, H | 1 |
| Ito, M; Segami, T; Suzuki, Y | 1 |
| Buljat, G; Gjurasin, M; Grabarević, Z; Hanzevacki, M; Jadrijević, S; Jagić, V; Jelovac, N; Jurina, L; Konjevoda, P; Marović, A; Miklić, P; Mikus, D; Mise, S; Perić, J; Perović, D; Petek, M; Rotkvić, I; Rucman, R; Seiwerth, S; Separović, J; Sikirić, P; Turković, B; Zoricić, I | 1 |
| Hirata, T; Kato, S; Kitamura, M; Takeuchi, K | 1 |
| Fung, LC; Greenberg, GR | 1 |
| Akagi, K; Hasebe, K; Nagao, T; Urushidani, T; Watanabe, K | 1 |
| Aralica, G; Desković, S; Grabarević, Z; Jadrijević, S; Konjevoda, P; Marović, A; Perović, D; Petek, M; Rucman, R; Seiwerth, S; Sikirić, P; Sosa, T; Turković, B | 1 |
| Anic, T; Aralica, G; Bilic, I; Buljat, G; Ivankovic, D; Mikus, D; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Zoricic, I | 1 |
| Hollenberg, MD; Irimajiri, K; Kawabata, A; Kawai, K; Kawao, N; Kuroda, R; Nishida, S; Nishikawa, H; Sakaguchi, Y; Tagome, A | 1 |
| Funakoshi, A; Kanai, S; Kurosawa, M; Masuda, M; Miyasaka, K; Sato, N | 1 |
| Anic, T; Batelja, L; Bedekovic, V; Boban Blagaic, A; Drvis, P; Gjurasin, M; Kalogjera, L; Kopljar, M; Mise, S; Seiwerth, S; Sikiric, P; Staresinic, M | 1 |
| Hayashi, Y; Kubo, Y; Takeuchi, K; Tanaka, A | 1 |
| Itoh, M; Joh, T; Kaneko, H; Kataoka, H; Nomura, T; Ohara, H; Oshima, T; Sasaki, M; Sobue, M; Suzuki, H; Takahashi, N; Watanabe, K | 1 |
| Cunha-Melo, JR; da Conceição, SA; da Luz, MM; de Araújo, GK; Lisboa, FA; Melo, JR; Moraes-Santos, T | 1 |
| Takahira, Y; Takeuchi, K; Tanaka, A; Taniguchi, M; Yokota, A | 1 |
| Amagase, K; Kobata, A; Kotani, T; Murashima, Y; Takeuchi, K | 1 |
| Anginoni, M; Baggio, CH; Finau, J; Freitas, CS; Marques, MC; Pizzolatti, MG; Santos, AR | 1 |
| Anic, T; Batelja, L; Berkopic, L; Blagaic Boban, A; Brcic, L; Cesarec, V; Coric, M; Dolovski, Z; Drmic, D; Ilic, S; Ivica, M; Klicek, R; Kocman, I; Kolenc, D; Lovric Bencic, M; Mise, S; Radic, B; Seiwerth, S; Sever, M; Sikiric, P; Skorjanec, S; Staresinic, M; Tonkic, A; Zoricic, I | 1 |
| Kanai, S; Miyasaka, K; Ohta, M; Suwa, Y; Tsutsumi, E | 1 |
| Czimmer, J; Mózsik, G; Szabó, IL; Szolcsányi, J | 1 |
| Chen, H; Lin, X; Lin, YN | 1 |
3 review(s) available for omeprazole and atropine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine | 2013 |
The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: a systematic review and meta-analysis.
Topics: Atropine; Gastritis; Humans; Omeprazole; Treatment Outcome | 2021 |
1 trial(s) available for omeprazole and atropine
| Article | Year |
|---|---|
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine | 2013 |
55 other study(ies) available for omeprazole and atropine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Influence of gastric acid on circulating somatostatin-14 and -28 released after insulin-induced hypoglycemia in conscious dogs.
Topics: Animals; Atropine; Blood Glucose; Chromatography, Gel; Dogs; Gastric Acid; Hypoglycemia; Insulin; Omeprazole; Pancreatic Polypeptide; Ranitidine; Somatostatin; Somatostatin-28; Time Factors | 1992 |
Stimulatory effects of islet amyloid polypeptide (amylin) on exocrine pancreas and gastrin release in conscious rats.
Topics: Amyloid; Animals; Atropine; Blood Glucose; Gastrins; Glucagon; Insulin; Islet Amyloid Polypeptide; Islets of Langerhans; Kinetics; Male; Omeprazole; Pancreas; Rats; Rats, Inbred Strains | 1992 |
Gastric acid and pepsin hypersecretion in conscious rabbits.
Topics: Animals; Atropine; Bethanechol; Bethanechol Compounds; Gastric Acid; Gastric Juice; Histamine; Male; Omeprazole; Pepsin A; Rabbits; Ranitidine; Stimulation, Chemical; Vagotomy | 1991 |
The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
Topics: Animals; Anti-Anxiety Agents; Atropine; Benzodiazepinones; Bethanechol Compounds; Cholecystokinin; Dose-Response Relationship, Drug; Gastric Acid; Gastrins; Histamine; Indoles; Male; Meglumine; Omeprazole; Phenylurea Compounds; Ranitidine; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin | 1991 |
Gastroduodenal ulcers in rats induced by 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): requirement for gastric acid secretion and the role of prostaglandins.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alprostadil; Animals; Atropine; Duodenal Ulcer; Female; Gastric Acid; Injections, Subcutaneous; Misoprostol; Omeprazole; Prostaglandins; Rats; Rats, Inbred F344; Stomach Ulcer; Time Factors | 1990 |
Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands.
Topics: Adenosine Triphosphatases; Aminopyrine; Ammonia; Animals; Anti-Ulcer Agents; Atropine; Bucladesine; Carbachol; Carbon Dioxide; Cimetidine; Gastric Mucosa; Glucose; Glycolysis; H(+)-K(+)-Exchanging ATPase; Histamine; Imidazoles; In Vitro Techniques; Kinetics; Models, Biological; Omeprazole; Oxygen Consumption; Rats | 1990 |
Capsaicin-sensitive afferent fibers contribute to gastric mucosal blood flow response to electrical vagal stimulation.
Topics: Afferent Pathways; Animals; Atropine; Capsaicin; Electric Stimulation; Gastric Acid; Gastric Mucosa; Kinetics; Male; Nerve Fibers; Omeprazole; Rats; Rats, Inbred Strains; Regional Blood Flow; Vagus Nerve | 1990 |
Effect of acute suppression of acid secretion by omeprazole on postprandial gastrin release in conscious dogs.
Topics: Animals; Atropine; Bombesin; Dogs; Eating; Gastric Acid; Gastrins; Hydrochloric Acid; Hydrogen-Ion Concentration; Insulin; Omeprazole; Somatostatin | 1989 |
Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
Topics: Adenosine Triphosphatases; Animals; Atropine; Gastric Acid; Guinea Pigs; H(+)-K(+)-Exchanging ATPase; Imipramine; In Vitro Techniques; Male; Omeprazole; Parietal Cells, Gastric; Promethazine; Ranitidine | 1988 |
Some profiles of transmucosal potential difference in rat stomach determined in situ with special reference to effects of timoprazole, a H+,K+-ATPase inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Atropine; Benzimidazoles; Bethanechol; Bethanechol Compounds; Cimetidine; Diphenhydramine; Gastric Acid; Gastric Mucosa; Histamine Antagonists; Male; Membrane Potentials; Omeprazole; Rats; Rats, Inbred Strains; Tetragastrin | 1986 |
Adrenergic agents stimulate and cholinergic agents inhibit H+ secretion by amphibian jejunum.
Topics: Acetazolamide; Animals; Atropine; Benzimidazoles; Bicarbonates; Electric Conductivity; Epinephrine; Intestinal Mucosa; Isoproterenol; Jejunum; Kinetics; Methacholine Chloride; Methacholine Compounds; Norepinephrine; Omeprazole; Parasympathomimetics; Protons; Sodium; Sympathomimetics; Urodela | 1986 |
Gastric surface epithelial cell damage induced by restraint and water-immersion stress in rats. Protective effects of 16,16-dimethyl-prostaglandin E2.
Topics: 16,16-Dimethylprostaglandin E2; 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Atropine; Benzimidazoles; Gastric Acid; Gastric Mucosa; Gastrointestinal Motility; Immersion; Male; Microscopy, Electron, Scanning; Omeprazole; Papaverine; Peptic Ulcer; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Physiological | 1988 |
Thioredoxin and thioredoxin reductase show function-related changes in the gastric mucosa: immunohistochemical evidence.
Topics: Animals; Atropine; Bacterial Proteins; Carbachol; Gastric Acid; Gastric Mucosa; Immunohistochemistry; Male; NADH, NADPH Oxidoreductases; Omeprazole; Pentagastrin; Rats; Rats, Inbred Strains; Thioredoxin-Disulfide Reductase; Thioredoxins; Vagotomy | 1988 |
Surface epithelial cell damage induced by restraint and water-immersion stress in rats effects of 16,16-dimethyl prostaglandin E2 on stress-induced gastric lesions.
Topics: 16,16-Dimethylprostaglandin E2; 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Atropine; Benzimidazoles; Epithelial Cells; Epithelium; Gastric Mucosa; Gastrointestinal Motility; Immersion; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Omeprazole; Papaverine; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Psychological | 1987 |
Effects of 16,16-dimethyl prostaglandin E2 on surface epithelial cell damage in the rat stomach induced by vagal nerve stimulation.
Topics: 16,16-Dimethylprostaglandin E2; 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Atropine; Benzimidazoles; Electric Stimulation; Epithelium; Gastric Acid; Gastric Mucosa; Gastrointestinal Motility; Hemodynamics; Male; Omeprazole; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains; Vagus Nerve | 1987 |
Pepsin secretion: neurohumoral regulation and drug effects.
Topics: Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bucladesine; Carbachol; Cimetidine; Cycloheximide; Gastric Acid; Gastrins; Histamine; In Vitro Techniques; Mice; Models, Biological; Omeprazole; Parasympatholytics; Pepsin A; Secretory Rate | 1984 |
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Aminopyrine; Animals; Atropine; Benzimidazoles; Bucladesine; Cimetidine; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Omeprazole; Potassium; Rabbits | 1981 |
Effect of omeprazole on gastric secretion in H+,K+-ATPase and in pepsinogen-rich cell fractions from rabbit gastric mucosa.
Topics: Adenosine Triphosphatases; Aminopyrine; Animals; Atropine; Benzimidazoles; Cell Separation; Centrifugation, Density Gradient; Cimetidine; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; In Vitro Techniques; Male; Microsomes; Omeprazole; Pepsinogens; Rabbits | 1984 |
Ultrastructure of inhibited parietal cells in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Atropine; Benzimidazoles; Cimetidine; Depression, Chemical; Gastric Acid; Gastric Mucosa; Male; Omeprazole; Rats; Rats, Inbred Strains; Surface Properties | 1984 |
Effect of cimetidine and omeprazole on gastric ulcer healing of rats with limited food intake time.
Topics: Acetates; Acetic Acid; Administration, Oral; Analysis of Variance; Animals; Atropine; Cimetidine; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Gastric Acid; Gastrins; Hydrogen-Ion Concentration; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Wound Healing | 1994 |
The role of thyrotropin-releasing hormone (TRH) in the pathogenesis of water-immersion stress in rats--inhibition of TRH release from the stomach by atropine, ranitidine or omeprazole.
Topics: Animals; Atropine; Bethanechol; Bethanechol Compounds; Gastric Acid; Gastric Juice; Gastric Mucosa; Immersion; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Physiological; Thyrotropin-Releasing Hormone | 1993 |
Mechanisms behind changes in gastric acid and bicarbonate outputs during the human interdigestive motility cycle.
Topics: Adolescent; Adult; Atropine; Bicarbonates; Digestion; Female; Gastric Acid; Gastrointestinal Motility; Humans; Male; Middle Aged; Myoelectric Complex, Migrating; Omeprazole; Pylorus | 1996 |
Simultaneous evaluation of gastric and duodenal ulcers-healing activities of anti-ulcer agents in rats.
Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Atropine; Chronic Disease; Cimetidine; Duodenal Ulcer; Histamine; Male; Muscarinic Antagonists; Omeprazole; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1996 |
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies.
Topics: Animals; Anti-Ulcer Agents; Atropine; Bromocriptine; Cimetidine; Cysteamine; Duodenal Ulcer; Female; Gastrectomy; Omeprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar | 1997 |
Gastric hyperemic response during vagally mediated acid secretion by TRH analog in rats.
Topics: Animals; Atropine; Azetidines; Blood Pressure; Dipeptides; Gastric Acid; Gastric Mucosa; Hyperemia; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Omeprazole; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vagus Nerve | 1997 |
Somatostatin-14 modulates acid-dependent inhibition of meal-stimulated gastrin via muscarinic pathways in dogs.
Topics: Animals; Anti-Ulcer Agents; Atropine; Dogs; Eating; Gastric Acid; Gastrins; Muscarine; Muscarinic Antagonists; Omeprazole; Postprandial Period; Somatostatin | 1998 |
Gastric acid secretion is augmented by the replacement of extracellular Na+ with K+ or other ions.
Topics: 1-Methyl-3-isobutylxanthine; Aminopyrine; Animals; Atropine; Bucladesine; Calcium; Carbachol; Carcinogens; Cations; Cimetidine; Cyclic AMP; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; In Vitro Techniques; Male; Mice; Muscarinic Agonists; Muscarinic Antagonists; Omeprazole; Potassium; Rabbits; Rotenone; Sodium; Stomach; Tetradecanoylphorbol Acetate; Uncoupling Agents; Vagus Nerve | 1998 |
New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin.
Topics: Amino Acid Sequence; Anastomosis, Surgical; Animals; Anti-Ulcer Agents; Atropine; Cyclooxygenase Inhibitors; Cytoprotection; Dose-Response Relationship, Drug; Ethanol; Gastric Mucosa; Indomethacin; Irritants; Jejunum; Male; Molecular Sequence Data; Omeprazole; Peptic Ulcer; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Stomach | 1999 |
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bromocriptine; Cimetidine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indomethacin; Lansoprazole; Male; Mice; Mice, Inbred Strains; Misoprostol; Omeprazole; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Stomach Diseases; Sulfoxides | 2001 |
Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion.
Topics: Animals; Atropine; Capsaicin; Gastric Mucosa; Immunohistochemistry; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Omeprazole; Pepsin A; Pepsinogen A; Rats; Rats, Wistar; Receptor, PAR-2; Receptors, Thrombin; Stomach | 2002 |
Central Orexin-A stimulates pancreatic exocrine secretion via the vagus.
Topics: Animals; Atropine; Carrier Proteins; Ganglionic Blockers; Hexamethonium; Injections, Intravenous; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Kinetics; Male; Neuropeptides; Omeprazole; Orexins; Pancreas; Rats; Rats, Wistar; Vagus Nerve | 2002 |
Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy.
Topics: Animals; Anti-Ulcer Agents; Atropine; Cysteamine; Duodenal Ulcer; Female; Gastrectomy; Omeprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Submandibular Gland | 2003 |
Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
Topics: Animals; Atropine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastrointestinal Motility; Indomethacin; Isoenzymes; Lactones; Male; Omeprazole; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stomach; Stomach Ulcer; Sulfones | 2004 |
Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration.
Topics: Animals; Anti-Ulcer Agents; Atropine; Brain; Gastric Mucosa; Hydrochloric Acid; Injections, Intraventricular; Male; Muscarinic Antagonists; Omeprazole; Permeability; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Thyrotropin-Releasing Hormone; Vagotomy | 2005 |
Effect of acid secretion blockade on acute gastric mucosal lesions induced by Tityus serrulatus scorpion toxin in anaesthetized rats.
Topics: Acute Disease; Anesthesia; Animals; Atropine; Cimetidine; Dose-Response Relationship, Drug; Drug Antagonism; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Gastrointestinal Agents; Male; Neurotoxins; Octreotide; Omeprazole; Pepsin A; Ranitidine; Rats; Scorpion Venoms; Stomach Diseases | 2006 |
Dexamethasone damages the rat stomach but not small intestine during inhibition of COX-1.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Atropine; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Gastric Mucosa; Gastrointestinal Motility; Gene Expression; Intestinal Mucosa; Intestine, Small; Male; Muscarinic Antagonists; Nitric Oxide Synthase Type II; Omeprazole; Pyrazoles; Rats; Rats, Sprague-Dawley; Stomach | 2007 |
Pathogenic importance of pepsin in ischemia/reperfusion-induced gastric injury.
Topics: Animals; Anti-Ulcer Agents; Atropine; Cimetidine; Dose-Response Relationship, Drug; Male; Omeprazole; Pepsin A; Pepstatins; Pylorus; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2007 |
Inhibition of H+/K+ ATPase in the gastroprotective effect of Baccharis illinita DC.
Topics: Animals; Atropine; Baccharis; Bethanechol; Dose-Response Relationship, Drug; Female; Flowers; Gastric Acid; Gastric Acidity Determination; H(+)-K(+)-Exchanging ATPase; Histamine; Luteolin; Omeprazole; Pentagastrin; Plant Extracts; Proton Pump Inhibitors; Rats; Rats, Wistar; Stomach | 2008 |
Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole.
Topics: Adrenal Cortex Hormones; Animals; Anti-Ulcer Agents; Atropine; Cutaneous Fistula; Disease Models, Animal; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer; Wound Healing | 2009 |
Stimulatory effect of N-methyltyramine, a congener of beer, on pancreatic secretion in conscious rats.
Topics: Amylases; Animals; Atropine; Beer; Benzodiazepines; Gastrins; Infusions, Intravenous; Injections; Male; Omeprazole; Pancreas; Pancreatic Juice; Proglumide; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Solutions; Stomach; Tyramine | 2010 |